Back to previous page

Clinical trials

Sarah Cannon Research Institute UK (SCRIUK) is HCA’s clinical trials unit.

It is the first trials unit outside the NHS that can offer new anti-cancer drugs in clinical trials. SCRI is collaborating and working closely with clinical investigators to develop new and innovative cancer treatments.

As a dedicated trials unit, the SCRI aims to offer patients rapid access to new investigational drug treatments – importantly this is open to both private and NHS patients.

Search here to learn more about what trials are running at the moment. If you are interested in being considered for a trial, ask your consultant for more information.

Sarah-Cannon-Logo